Potassium Acetate Injection Shortage
Last Updated: October 9, 2020
Status: Resolved
Reason for the Shortage
-
- Pfizer had potassium acetate on shortage due to manufacturing delays.
- Exela had potassium acetate on allocation to prevent hoarding.
Available Products
-
- Potassium acetate injection, Exela Pharma Sciences, 2 mEq/mL, 20 mL vial, 25 count, NDC 51754-2001-04
- Potassium acetate injection, Pfizer, 2 mEq/mL, 20 mL vial, 25 count, NDC 00409-8183-01
- Potassium acetate injection, Pfizer, 2 mEq/mL, 50 mL vial, 25 count, NDC 00409-3924-51
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated October 9, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 6, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.